The analysis revealed that the mRNA level of JMJD6 was up-regulated in a variety of cancers, including thyroid cancer, ovarian cancer, breast cancer, prostate cancer, lung adenocarcinomas, liver cancer, colorectal cancer and melanoma (Fig. 1a). Here, JMJD6 is linked to prostate carcinoma.